Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

for the ACTION Learning Network, Adult Congenital Heart Disease Sub-Committee

doi:10.1111/chd.12851

Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

for the ACTION Learning Network, Adult Congenital Heart Disease Sub-Committee

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Background: There are no published data on post-transplant outcomes in durable ventricular assist device (VAD)-supported adult congenital heart disease (ACHD) patients. Methods: We compared post-transplant outcomes in VAD-supported vs non-VAD-supported ACHD patients using the Scientific Registry of Transplant Recipients. Results: At 1 year, there was no difference in post-transplant mortality between VAD-supported (12 patients) and non-VAD-supported (671 patients) ACHD patients. Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

Original language	English (US)
Pages (from-to)	958-962
Number of pages	5
Journal	Congenital Heart Disease
Volume	14
Issue number	6
DOIs	https://doi.org/10.1111/chd.12851
State	Published - Nov 1 2019

Keywords

adult congenital heart disease
heart transplant
ventricular assist device

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Surgery
Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1111/chd.12851

Cite this

@article{c4d5c78ea6524293b6ca134acc9c021d,

title = "Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease",

abstract = "Background: There are no published data on post-transplant outcomes in durable ventricular assist device (VAD)-supported adult congenital heart disease (ACHD) patients. Methods: We compared post-transplant outcomes in VAD-supported vs non-VAD-supported ACHD patients using the Scientific Registry of Transplant Recipients. Results: At 1 year, there was no difference in post-transplant mortality between VAD-supported (12 patients) and non-VAD-supported (671 patients) ACHD patients. Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.",

keywords = "adult congenital heart disease, heart transplant, ventricular assist device",

author = "{for the ACTION Learning Network, Adult Congenital Heart Disease Sub-Committee} and Ari Cedars and Luke Burchill and Roche, {S. Lucy} and Jonathan Menachem and Kelly Axsom and Kristen Tecson",

note = "Funding Information: Funding information Divisional funding from UT Soutwestern Medical School. Publisher Copyright: {\textcopyright} 2019 Wiley Periodicals, Inc.",

year = "2019",

month = nov,

day = "1",

doi = "10.1111/chd.12851",

language = "English (US)",

volume = "14",

pages = "958--962",

journal = "Congenital Heart Disease",

issn = "1747-079X",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

AU - for the ACTION Learning Network, Adult Congenital Heart Disease Sub-Committee

AU - Cedars, Ari

AU - Burchill, Luke

AU - Roche, S. Lucy

AU - Menachem, Jonathan

AU - Axsom, Kelly

AU - Tecson, Kristen

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background: There are no published data on post-transplant outcomes in durable ventricular assist device (VAD)-supported adult congenital heart disease (ACHD) patients. Methods: We compared post-transplant outcomes in VAD-supported vs non-VAD-supported ACHD patients using the Scientific Registry of Transplant Recipients. Results: At 1 year, there was no difference in post-transplant mortality between VAD-supported (12 patients) and non-VAD-supported (671 patients) ACHD patients. Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

AB - Background: There are no published data on post-transplant outcomes in durable ventricular assist device (VAD)-supported adult congenital heart disease (ACHD) patients. Methods: We compared post-transplant outcomes in VAD-supported vs non-VAD-supported ACHD patients using the Scientific Registry of Transplant Recipients. Results: At 1 year, there was no difference in post-transplant mortality between VAD-supported (12 patients) and non-VAD-supported (671 patients) ACHD patients. Conclusions: In appropriate ACHD patients, VAD use as a bridge to transplant is a reasonable strategy.

KW - adult congenital heart disease

KW - heart transplant

KW - ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85074248715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074248715&partnerID=8YFLogxK

U2 - 10.1111/chd.12851

DO - 10.1111/chd.12851

M3 - Article

C2 - 31625684

AN - SCOPUS:85074248715

SN - 1747-079X

VL - 14

SP - 958

EP - 962

JO - Congenital Heart Disease

JF - Congenital Heart Disease

IS - 6

ER -

Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this